Strong Evidence Base Dario has surpassed 100 scientific studies, including peer-reviewed publications, establishing it as a highly evidence-based digital health platform. This positions Dario as a trusted partner for healthcare organizations seeking proven outcomes, making it an attractive solution for clients prioritizing validated efficacy.

Growing Client Portfolio With 79 new employer clients signed in 2025, exceeding its target by nearly double, Dario demonstrates strong market adoption and scalability within the employer health segment. This growth indicates significant sales opportunities in mid-size and large organizations looking for effective digital health solutions.

Innovative AI Integration The launch of DarioIQ™ AI layer introduces advanced conversational AI to enhance chronic condition management, specifically for hypertension. This innovation offers a compelling upsell or cross-sell potential for clients interested in AI-driven engagement to improve health outcomes and member experiences.

Proven Cost Savings Studies showing an estimated $5,077 annual medical cost savings per user highlight Dario’s ability to reduce healthcare utilization and costs for employers. This cost-saving metric is a strong selling point for organizations aiming to lower their healthcare expenses through digital intervention programs.

Evidence of Clinical Impact Real-world data demonstrating significant and sustained improvements in blood pressure and reductions in hospitalizations and healthcare charges underscores Dario’s ability to deliver meaningful clinical outcomes. Targeting healthcare providers and payers interested in evidence-based, outcome-driven solutions presents a significant sales opportunity.